Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.
Emmanouil Karteris
Dr Emmanouil Karteris is a Reader at Brunel University London, Head of Cancer Biomarkers and Cellular Endocrinology Lab (www.cbcel.org), and Departmental Director International for Life Sciences. He gained his BSc degree in Medical Biochemistry (University of Surrey, UK, 1995), MSc in Medical Genetics with Immunology (Brunel University, UK 1996) and his PhD (Warwick University, UK 2000). Dr Karteris has published 96 research manuscripts (h-index 33, i10-index:67) and presented over 100 abstracts in leading international conferences. He also has expertise IP law and in setting up clinical studies. His lab -in collaboration with oncologists nationwide- primarily works on the clinical utility of liquid biopsies, namely characterization and enumeration of circulating tumour cells, measurements of cfDNA and ctDNA, as well as RNA-sequencing analyses.
